Efficacy and Safety of Subcutaneous Golimumab in Methotrexate‐Naive Patients With Rheumatoid Arthritis: Five‐Year Results of a Randomized Clinical Trial
Emery, Paul, Fleischmann, Roy M., Strusberg, Ingrid, Durez, Patrick, Nash, Peter, Amante, Eric Jason B., Churchill, Melvin, Park, Won, Pons‐Estel, Bernardo, Han, Chenglong, Gathany, Timothy A., Xu, Stephen, Zhou, Yiying, Leu, Jocelyn H., Hsia, Elizabeth C.
Published in Arthritis care & research (2010) (01.06.2016)
Published in Arthritis care & research (2010) (01.06.2016)
Get full text
Journal Article
Intravenous Tocilizumab versus Standard of Care in the Treatment of Severe and Critical COVID-19-related Pneumonia: A Single-center, Double-blind, Placebo-controlled, Phase 3 Trial
Amante, Eric Jason B, David-Wang, Aileen S, Tee, Michael L, Punzalan, Felix Eduardo R, Añonuevo, John C, Fernandez, Lenora C, Albay, Jr, Albert B, Malabad, John Carlo M, Climacosa, Fresthel Monica M, Pajes, A Nico Nahar I, Cuaño, Patricia Maria Gregoria M, Alejandría, Marissa M
Published in Acta medica Philippina (2024)
Published in Acta medica Philippina (2024)
Get full text
Journal Article
Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate‐naive patients with active rheumatoid arthritis: Twenty‐four–week results of a phase III, multicenter, randomized, double‐blind, placebo‐controlled study of golimumab before methotrexate as first‐line therapy for early‐onset rheumatoid arthritis
Emery, Paul, Fleischmann, Roy M., Moreland, Larry W., Hsia, Elizabeth C., Strusberg, Ingrid, Durez, Patrick, Nash, Peter, Amante, Eric Jason B., Churchill, Melvin, Park, Won, Pons‐Estel, Bernardo Antonio, Doyle, Mittie K., Visvanathan, Sudha, Xu, Weichun, Rahman, Mahboob U.
Published in Arthritis and rheumatism (01.08.2009)
Published in Arthritis and rheumatism (01.08.2009)
Get full text
Journal Article
Erratum: Golimumab, a human anti‐tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate‐naive patients with active rheumatoid arthritis: Twenty‐four‐week results of a phase III, multicenter, randomized, double‐blind, placebo‐controlled study of golimumab before methotrexate as first‐line therapy for early‐onset rheumatoid arthritis
Emery, Paul, Fleischmann, Roy M., Moreland, Larry W., Hsia, Elizabeth C., Strusberg, Ingrid, Durez, Patrick, Nash, Peter, Amante, Eric Jason B., Churchill, Melvin, Park, Won, Pons‐Estel, Bernardo Antonio, Doyle, Mittie K., Visvanathan, Sudha, Xu, Weichun, Rahman, Mahboob U.
Published in Arthritis and rheumatism (01.09.2010)
Published in Arthritis and rheumatism (01.09.2010)
Get full text
Journal Article